SCHEMBL4034006

SCHEMBL4034006

O=C(NCCC(F)(F)F)[C@@H]1Cc2ccccc2N1S(=O)(=O)c1ccc(-c2ccccc2C(F)(F)F)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 1/20 0.40
MMP2 P08253 1/20 0.40
MMP9 P14780 1/20 0.40
MMP14 P50281 1/20 0.40
ADAM17 P78536 1/20 0.40
PTGER3 P43115 1/20 0.40
KDM2B Q8NHM5 1/20 0.40
SCN9A Q15858 1/20 0.40
MMP8 P22894 6/20 0.39
MMP3 P08254 3/20 0.39
RORC P51449 1/20 0.37
MAPK1 P28482 1/20 0.37
PSEN1 P49768 1/20 0.37
PSEN2 P49810 1/20 0.37
APH1B Q8WW43 1/20 0.37
NCSTN Q92542 1/20 0.37
APH1A Q96BI3 1/20 0.37
PSENEN Q9NZ42 1/20 0.37
LMNA P02545 1/20 0.36
MCL1 Q07820 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4032860 0.95 MAPK1 (0.40) MMP1MMP2MMP9MMP14ADAM17
SCHEMBL4039147 0.91 RORC (0.42) MMP1MMP2MMP9MMP14ADAM17
SCHEMBL4842900 0.89 FFAR4 (0.43) MMP1MMP2MMP9MMP14ADAM17
SCHEMBL4841693 0.88 FFAR4 (0.43) MMP1MMP2MMP9MMP14ADAM17
SCHEMBL4840706 0.87 FFAR4 (0.42) MMP1MMP2MMP9MMP14ADAM17
SCHEMBL4033863 0.87 LMNA (0.45) MMP1MMP2MMP9MMP14ADAM17
SCHEMBL4036392 0.87 POLB (0.42) MMP1MMP2MMP9MMP14ADAM17
SCHEMBL4203772 0.87 MAPK1 (0.42) MMP1MMP2MMP9MMP14ADAM17
SCHEMBL4842444 0.87 MAPK1 (0.40) MMP1MMP2MMP9MMP14ADAM17
SCHEMBL4035938 0.87 PSEN1 (0.47) MMP1MMP2MMP9MMP14ADAM17

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1885695-B1 INDOLINE COMPOUNDS FOURNIER LAB SA (FR) 2009-02-25 EP disclosed
US-7465811-B2 Indoline compounds LABORATOIRES FOURNIER S.A. (FR) 2008-12-16 US disclosed
US-20080119465-A1 Novel Indoline Compounds LABORATORIES FOURNIER S.A. (FR) 2008-05-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080119465-A1 Novel Indoline Compounds GPR119, INSR, IRS1 MMP1 3209/4885MMP2 3541/4885MMP9 4080/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.